Sponsor intelligence · INDUSTRY
Clinical trials sponsored by
The United Bio-Technology (Hengqin) Co., Ltd..
Real, source-linked trial activity for The United Bio-Technology (Hengqin) Co., Ltd.: 4 tracked trials, by phase and status, newest first. New trials = pipeline expansion = CRO, site, and reagent demand.
✔ Verified against the public NIH RePORTER & ClinicalTrials.gov records as of Oct 15, 2026. Source-linked, daily-refreshed.
PHASE1 2PHASE3 2
Newest The United Bio-Technology (Hengqin) Co., Ltd. trials
| Posted | Trial | Phase | Status | |
|---|---|---|---|---|
| 1d ago | Study of UBT37034 Injection | Ph 1 | NOT_YET_RECRUITING | ↗ |
| 37d ago | UBT251 Injection Phase Ⅲ Study (OSA-PAP) | Ph 3 | NOT_YET_RECRUITING | ↗ |
| 51d ago | Phase I Drug-Drug Interaction Study of UBT251 Injection in Participant | Ph 1 | RECRUITING | ↗ |
| 59d ago | Phase III Trial of UBT251 in Moderate-to-Severe OSA With Obesity: A Ra | Ph 3 | NOT_YET_RECRUITING | ↗ |
Get this lane pushed to you the day a new grant or trial lands
Free email digest + a daily new-funding feed (JSON / MCP / webhook) of newly-awarded NIH grants and newly-registered clinical trials for The United Bio-Technology (Hengqin) Co., Ltd. (trial sponsor). Watch institutions, PIs, sponsors, and topics. Newly-funded labs = new buyers, today.